ENST00000528540.5:c.-124A>G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000528540.5(CD3G):c.-124A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000701 in 1,569,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000528540.5 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD3G | NM_000073.3 | c.40A>G | p.Ile14Val | missense_variant | Exon 1 of 7 | ENST00000532917.3 | NP_000064.1 | |
CD3G | NM_001440319.1 | c.40A>G | p.Ile14Val | missense_variant | Exon 1 of 7 | |||
CD3G | XM_005271724.5 | c.40A>G | p.Ile14Val | missense_variant | Exon 1 of 4 | XP_005271781.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000553 AC: 1AN: 180954 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000353 AC: 5AN: 1417434Hom.: 0 Cov.: 31 AF XY: 0.00000571 AC XY: 4AN XY: 700516 show subpopulations
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74358 show subpopulations
ClinVar
Submissions by phenotype
Combined immunodeficiency due to CD3gamma deficiency Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with CD3G-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces isoleucine with valine at codon 14 of the CD3G protein (p.Ile14Val). The isoleucine residue is weakly conserved and there is a small physicochemical difference between isoleucine and valine. -
CD3G-related disorder Uncertain:1
The CD3G c.40A>G variant is predicted to result in the amino acid substitution p.Ile14Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.015% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-118215178-A-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at